Skip to main content .


BARDA supports development of two automated antibody tests for COVID-19 by Ortho Clinical Diagnostics

BARDA Response

BARDA is pleased to announce a partnership with Ortho Clinical Diagnostics to further develop two automated antibody tests for COVID-19.

The VITROS® Anti-SARS-COV-2 Total test detects all COVID-19 related antibodies (IgG, IgM and IgA) and the VITROS® Anti-SARS-COV-2 IgG test detects the IgG antibody, which appears in a patient’s blood in the later phase of infection and remains elevated even after recovery.

These tests offer choices in tracking, surveillance and patient management and may be useful in identifying people who have recovered from COVID-19 and could be eligible to donate convalescent plasma for use as a possible treatment for hospitalized COVID-19 patients.

Both tests can run on Ortho’s high-throughput, random access, fully-automated VITROS® Systems including the VITROS® XT 7600 Integrated System, the VITROS® 3600 Immunodiagnostic System, the VITROS® 5600 Integrated System, and the VITROS® ECi/ECiQ Immunodiagnostic Systems. Ortho has already installed these analyzers in more than 1,000 hospitals and labs across the U.S.

Ortho Clinical Diagnostics plans to manufacture several millions of tests per week.

This award is one component of BARDA’s rapidly expanding COVID-19 medical countermeasure portfolio; visit BARDA’s COVID-19 Portfolio to learn more.

About the Company:

The following information is provided by the company and does not indicate endorsement by the federal government of the company or its products.

Ortho Clinical Diagnostics a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, serves the clinical laboratory and immunohematology communities. Ortho’s high-quality products and services help hospitals, hospital networks, blood banks and labs in more than 125 countries and territories deliver consistently fast, accurate, and reliable results that allow clinicians to make better-informed treatment decisions. Ortho’s lab solutions provide sophisticated testing technologies, automation, information management, and interpretation tools to clinical laboratories to help them run more efficiently and effectively and improve patient care. Ortho’s blood typing products help ensure every patient receives blood that is safe, the right type and the right unit.

For more information about Ortho’s solutions and services, visit https://www.orthoclinicaldiagnostics.com.

Last Updated: June 17, 2020

Website Refresh

www.medicalcountermeasures.gov is pleased to announce a phased launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience. Over the next several months you will see differences throughout the site while we continue implementing updates. Thank you for your understanding and please let us know if you have any questions: techwatchinbox@hhs.gov